Key lawmakers pressure Biden to preserve telehealth prescribing of effective addiction treatment

Key federal lawmakers are pressuring the Drug Enforcement Administration to preserve health providers’ ability to prescribe a highly effective opioid addiction treatment via telehealth.

In a letter delivered to the Biden administration on Wednesday, a bipartisan group led by Rep. Annie Kuster (D-N.H.) urged the DEA to continue allowing health providers to prescribe buprenorphine, a controlled substance used to treat opioid addiction, without requiring an in-person visit.

Prior to the Covid-19 pandemic, any patient who needed a controlled substance was required to be examined in person before receiving a prescription. But in early 2020, the DEA issued an emergency waiver that allowed health providers to prescribe the medications remotely. That waiver is set to expire at the end of 2024.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis

Reducing or eliminating alcohol consumption reduces the risk of developing oral cavity and esophagus cancers, according to a special report from the International Agency for

December 27, 2023

R1 RCM Acquires Acclara for $675M, Secures 10-Year RCM Partnership with Providence Health System

What You Should Know: – R1 RCM Inc. (NASDAQ: RCM), a provider of technology-driven solutions for healthcare providers, announced a significant strategic partnership involving the

December 8, 2023

New deep-learning framework identifies non-addictive pain relief options

An estimated one in five Americans live with chronic pain and current treatment options leave much to be desired.

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.